Cargando…
Molecular Mechanisms Underlying the Effects of Statins in the Central Nervous System
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, commonly referred to as statins, are widely used in the treatment of dyslipidaemia, in addition to providing primary and secondary prevention against cardiovascular disease and stroke. Statins’ effects on the central nervous system (CNS), p...
Autores principales: | McFarland, Amelia J., Anoopkumar-Dukie, Shailendra, Arora, Devinder S., Grant, Gary D., McDermott, Catherine M., Perkins, Anthony V., Davey, Andrew K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264186/ https://www.ncbi.nlm.nih.gov/pubmed/25391045 http://dx.doi.org/10.3390/ijms151120607 |
Ejemplares similares
-
Cellular Effects of Pyocyanin, a Secreted Virulence Factor of Pseudomonas aeruginosa
por: Hall, Susan, et al.
Publicado: (2016) -
Statins Reduce Lipopolysaccharide-Induced Cytokine and Inflammatory Mediator Release in an In Vitro Model of Microglial-Like Cells
por: McFarland, A. J., et al.
Publicado: (2017) -
Protection against Radiotherapy-Induced Toxicity
por: Hall, Susan, et al.
Publicado: (2016) -
Cyclooxygenase-2 inhibitors delay relapse and reduce Prostate Specific Antigen (PSA) velocity in patients treated with radiotherapy for nonmetastatic prostate cancer: a pilot study
por: King, Liam, et al.
Publicado: (2020) -
Putative involvement of sirtuin modulators in LPS-induced sickness behaviour in mice
por: Kinra, Manas, et al.
Publicado: (2022)